Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 90 for “"RESTENOSIS"”.
-
Restenosis of Coronary Artery Disease on the Implementation of Family Support and Health Behavior Research
… health behavior compliance for coronary artery restenosis patients helping prevent re-stenosis and promote health behavior. Subjects of the study were 80 patients were enrolled who got medical or surgical re-intervention after PCI for coronary artery re-stenosis at a general hospital at …
-
Plasma tissue factor, tissue factor pathway inhibitor and restenosis following femoropopliteal percutaneous transluminal angioplasty in claudicants
… disease progression while awaiting PTA Moreover restenosis following PTA is a major therapeutic problem despite high initial success rate, limiting the long-term efficacy of the procedure. There is growing evidence that the tissue factor-tissue factor pathway inhibitor (TF-TFPI) interaction, a …
-
Multi-modality Imaging to Determine the Role of Calcification and Inflammation on Restenosis Rates Following Lower Limb Angioplasty
… major cause of CVD-related death and disability. Restenosis is common, occurring in 40-60% of cases at 12 months following lower extremity percutaneous transluminal angioplasty (PTA). No such method exists to identify patients who are at risk from restenosis before intervention. Tracers of …
-
The role of altered cyclic strain patterns on proliferation and apoptosis of vascular smooth muscle cells - implications for in-stent restenosis
… main drawback of stent implantation is in-stent restenosis. Restenosis is a partial re-occlusion of the arterial wall predominantly due to vascular smooth muscle cells (SMC) migration from the media to the intima and subsequent SMC proliferation. A stent procedure dramatically alters the level of …
-
Inhibition of Vascular Smooth Muscle Cell Migration and Intimal Thickening with Chimeric N-Cadherin Mimetic Peptides: Development of a Novel Therapeutic Strategy for Restenosis
… and stenting, which has side effects of restenosis (re-narrowing) from smooth muscle cell (SMC) migration and proliferation, and late thrombosis due to endothelial cell (EC) death from indiscriminately cytotoxic chemotherapeutic agents. We developed a chimeric peptide with a mimetic …
-
Haematopoietic progenitor cells in carotid disease
… significant carotid disease or correlate with restenosis following carotid endarterectomy (CEA). Methods Initially the assay conditions to measure HPC number and function were optimized. HPC numbers were measured by flow cytometry (CD133+ve/CD34+ve) and early colony forming unit assay (eCFU). …
-
RHAMM Alters Vascular Smooth Muscle Cell Constrictive Matrix Remodeling
Restenosis, which is defined as a new lumen narrowing at the site of previous vascular reconstruction, affects millions of patients each year worldwide. Restenosis has been a major limitation of surgical and endovascular reconstructions since their inception and while decades of research have …
-
Evaluation eines Tacrolimus-beschichteten Stents zur Prävention der Restenosierung im diabetischen Tiermodell
In spite of improved technical methods, restenosis following stent implantation remains a central problem in interventional cardiology, especially in diabetic patients. Eminent for the development of restenosis are the proliferation of smooth muscle cells, the production of extracelluar matrix and …
-
Korrelation von genetischen Polymorphismen mit dem Schweregrad der Intimahyperplasie nach Stentimplantation
The instent-restenosis after coronary implantation is today the predominant problem in the cardiology. Many variables have been put in connection with instent-retenosis. After a pilot study on 100 patients this job investigated the influence of the PAI-1 promoter polymorphism on the "late loss" (a …
-
Hemocompatible polymer thin films fabricated by Electrostatic Self-Assembly (ESA)
… the arteries. The major complication of stent is restenosis. Current development of drug-eluting stents shows successfully reduce the occurrence of restenosis. Other than using drugs, electrostatic self assembled (ESAd) thin films may be the potential candidates to prevent restenosis. ESA is a …
-
Hochfrequenzrotablation zur Behandlung von Restenosen in Koronarstents
… atherectomy (RA) in case of an in-stent restenosis (ISR) and it assesses the results of adjunct balloon angioplasty (BA) and describes the predictors for a recurrent restenosis. ISR has become an important implication in interventional cardiology, mostly due to the increased rate of …
-
Etablierung und Charakterisierung eines diabetischen Tiermodells zur Stent-Restenose
… of developing coronary artery disease as well as restenosis following coronary stent implantation than non-diabetics, despite tremendous advances in the fields of diabetology and invasive cardiology. Surprisingly, no acceptable diabetic animal model of in-stent restenosis has been developed to the …
-
Experimentelle Untersuchungen am porzinen „over-sized coronary stent“-
… over-sized coronary stent-model for in-stent-restenosis rate after implantation of uncoated niob-zirkonium stents and niob-zirkonium stents coated with iridiumoxide. Background: The treatment of atherosclerotic stenosis in coronary artery disease with balloon expandable coronary stents has …
-
DRUG ELUTING TISSUE ENGINEERED VASCULAR GRAFTS
… due to poor patency outcomes with high rates of restenosis secondary to a phenomenon called Intimal Hyperplasia (IH). We have performed previous animal studies using 2mm TEVG in rabbits and 5mm TEVG in sheep which had restenosis rates secondary to IH of 70% and 60% respectively. IH is secondary …
-
Mechanismen der Restenosierung nach koronarer Stentimplantation : ein Paargruppenvergleich zwischen Diabetikern und Nicht-Diabetikern
… mellitus is an established risk factor for stent restenosis, in part as a result of smaller vessel dimensions and longer lesions. Aim of this study was to compare the magnitude of acute lumen gain and late lumen loss after elective coronary stent implantation in diabetic and non-diabetic patients …
-
Characterization of Everolimus In Biodegradable PLAF/PLEOF Nanoparticle
… stents (DES) have prolonged the progression of restenosis in coronary arteries, however, their use in larger vessels remain suboptimal. The drugs elude off within the first week, and a delayed release may retard development of restenosis in larger vessels. Therefore, biodegradable core-shell …
-
Reoxygenation of hypoxic coronary smooth muscle cells amplifies growth-retarding effects of ionizing irradiation
… potential targets for brachytherapy to prevent restenosis after percutaneous transluminal angioplasty. It is unclear whether gene expression, apoptosis rate and production of reactive oxygen species of these cells undergoing alpha-irradiation are changed by reoxygenation. <br>Hypoxic and …
-
Moesin in Thrombozyten interagiert mit PECAM-1 : Bedeutung für die Atherosklerose und Restenose
… fibroblasts of the arterial media in the case of restenosis after PTA use the mechanism of adhesion to form new cell-cell and cell-matrix contacts. Cell migration is a complex process, which is accompanied by changes of the cell-morphology, along with the rearrangement of the cytoskeleton, …
-
Endovaskuläre Brachytherapie mit Rhenium-188 zur Prophylaxe einer Restenose nach perkutaner transluminaler Angioplastie im peripheren Stromgebiet : klinische Studie und Literaturübersicht
… the ß-radiator rhenium 188 in order to prevent a restenosis in the femoropopliteal artery. Furthermore, to determine the individually required doses of rhenium 188 by intravascular ultrasound (IVUS) measurements of plaque morphology as well as to present an overview of current literature. By …
Page 1 of 5